NJCU Students Take Part in Mallinckrodt Pharmaceuticals 2019 Summer Interns Program
Mallinckrodt Pharmaceuticals executive and NJCU Foundation Board Trustee, Dagmar Rosa-Bjorkeson launched an initiative to introduce NJCU science majors to the pharmaceutical industry. Rosa-Bjorkeson’s staff worked with NJCU Foundation representatives, Gail Marquis and Cinthia Diaz. The NJCU Foundation made a site visit to Mallinckrodt Pharmaceuticals in Bedminster Township, NJ, viewed the workplace, met with executives from Rosa-Bjorkeson’s staff, and created the curriculum and application for internship positions.
Job descriptions were circulated to department chairs within the William J. Maxwell College of Arts and Sciences and the NJCU School of Business. Sixteen graduate and undergraduate students applied, and interviews were held on campus with Mallinckrodt executives and faculty.
The internship program was originally created for two student placements. Following the half day of interviews, five students and one alternate were selected to participate in the initial Mallinckrodt-NJCU Summer Interns Program.
The 10-week paid internship program began on June 17 and runs through to August 15, culminating in Final Presentations.
CAPTION: Pictured with Mark Trudeau, President and Chief Executive Officer, Mallinckrodt Pharmaceuticals (center), are (from left to right) NJCU students Merna Rezik, Thu Anh Le, Omar Aqani, and Joseph Salib.